Despite these results that suggest MIF-CD74 pathway plays a role in lupus pathology, a phase 1 clinical trial of an anti-MIF monoclonal antibody in lupus nephritis was terminated early for unclear reasons (112). The gene discussed is CD74; the disease is systemic lupus erythematosus.